Immunotherapy is increasingly used in earlier cancer stages before or after surgery across seven tumor areas. Research shows neoadjuvant and adjuvant immunotherapy can reduce recurrence risk and improve immune recognition of tumor cells. However, challenges remain including side effects, costs, and determining which patients benefit most from earlier treatment.
Study finds advanced melanoma patients with sufficient vitamin D levels showed better response rates and longer survival when receiving anti-PD-1 immunotherapy compared to those with low vitamin D status.
Pharmac has proposed expanding access to melanoma treatments and funding two new therapies for chronic lymphocytic leukaemia. Medical researchers also highlight that New Zealanders lack access to CAR T-cell therapy domestically.
Whole genome sequencing, comprehensive genomic profiling, and spatial multiomics are transforming precision medicine from research tools to clinical applications in oncology, rare diseases, and neonatal care, enabling faster diagnoses and personalized treatments.
Secondary analysis of KEYNOTE-716 trial finds adjuvant pembrolizumab improves recurrence-free survival in stage IIB/IIC melanoma without increasing new primary melanoma risk, while reducing non-melanoma skin cancers.
A study published in Science sequenced cancer-related genes in 493 cat tumor samples across 13 cancer types, revealing striking genetic similarities with human cancers and opening possibilities for shared treatments.
Immunotherapy is increasingly being used before and after surgery across seven cancer types, while the global immunotherapy drugs market experiences significant growth driven by advances in biotechnology and targeted therapies.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07510061 |
Title: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient Individuals |
RECRUITING | NA |
| NCT07436390 |
IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma |
COMPLETED | NA |
| NCT07429123 |
Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers |
COMPLETED | |
| NCT07426484 |
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy |
NOT_YET_RECRUITING | PHASE4 |
| NCT07422805 |
Circulating Tumor DNA in Melanoma Patients |
COMPLETED | NA |
| NCT07422779 |
Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia |
RECRUITING | NA |
| NCT07406022 |
Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis. |
NOT_YET_RECRUITING | |
| NCT07349940 |
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care |
RECRUITING | NA |
| NCT07330323 |
CARES : Customized Aftercare Report for Evaluated Skin Cancer Patients |
RECRUITING | NA |
| NCT07327489 |
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies |
RECRUITING |
